Newcastle University

Introduction

I am currently a Senior Research Associate with the Stroke Research Group. A clinician by background, I worked as a junior doctor in and around the Oxford area prior to moving to Newcastle upon Tyne. In Newcastle, I have worked in medical teaching and research, joining the Stroke Research Group in 2006.

Qualifications

MD                                                                           Newcastle University 2010

Postgraduate Certificate in Clinical Education          Newcastle University 2006

MRCP                                                                       Royal College of Physicians 2001

BM BCh                                                                    Oxford University 1998

BSc (Hons)                                                              St Andrews University 1995

Previous positions

Teaching and Education Fellow, Northumbria Healthcare NHS Foundation Trust

Specialist Registrar, Oxford Deanery

Senior House Officer posts, Oxford and London

House Officer posts, Oxford region

Research expertise 

I have worked as a researcher in stroke medicine since July 2006. During this time I have built up knowledge and expertise in the design, management and analysis of clinical trials. For my MD, I co-ordinated a 12 centre randomised controlled trial which evaluated the effectiveness of botulinum toxin for the treatment of upper limb spasticity after stroke. Since completion of my MD I have been involved in the design, conduct and analysis of further clinical trials to evaluate treatments for stroke.

Current research

1. Project manager and researcher for ‘Paramedic Initiated Lisinopril for Acute Stroke Treatment (PIL-FAST)’. This is a pilot randomised controlled trial led by Professor Gary Ford and funded by a NIHR programme grant.

2. Co-investigator and project manager for ‘A trial to evaluate an extended rehabilitation service for stroke patients’. This is a multicentre randomised controlled trial led by Professor Helen Rodgers and funded by NIHR HTA.

3. Co-investigator for ‘Development and feasibility evaluation of a repetitive functional task practice (RFTP) programme for upper limb recovery early after stroke’. This project is led by Professor Helen Rodgers and funded by The Stroke Association.

Research grants

1. A trial to evaluate an extended rehabilitation service for stroke patients.

Chief Investigator: Helen Rodgers.

Co-investigators: Robin Cant, Mark Deverill, Avril Drummond, Gary Ford, Anne Forster, Denise Howel, Anne-Marie Laverty, Chris McKevitt, Peter McMeekin, Chris Price, Lisa Shaw.

Funding: NIHR HTA 01.10.2012 – 30.09.2017

2. Development and feasibility evaluation of a repetitive functional task practice (RFTP) programme for upper limb recovery early after stroke.

Chief Investigator: Helen Rodgers.

Co-investigators: Anne Forster, Peter Langhorne, Chris Price, Lisa Shaw, Frederike van Wijck, Caroline Watkins.

Funding: The Stroke Association 01.09.2011 – 31.08.2014

Postgraduate supervision

I co-supervise Miss Lianne Brkic who is undertaking a PhD.

Projects

• A trial to evaluate an extended rehabilitation service for stroke patients (EXTRAS)
  Project Leader(s): Professor Helen Rodgers
• Development and feasibility evaluation of a repetitive functional task practice (RFTP) programme for upper limb recovery early after stroke.
  Project Leader(s): Professor Helen Rodgers

• Shackley P, Shaw L, Price C, VanWijck F, Barnes M, Graham L, Ford G, Steen N, Rodgers H. Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial. Toxins 2012, 4(12), 1415-1426.
• Shaw LC, Price CIM, van Wijck FMJ, Shackley P, Steen N, Barnes MP, Ford GA, Graham LA, Rodgers H. Botulinum Toxin for the Upper Limb After Stroke (BoTULS): TrialEffect on Impairment, Activity Limitation, and Pain. Stroke 2011, 42(5), 1371-1379.
• Shaw L, Price C, McLure S, Howel D, McColl E, Ford GA. Paramedic Initiated Lisinopril for Acute Stroke Treatment (PIL-FAST): study protocol for a pilot randomised controlled trial. Trials 2011, 12(1), 152.
• Shaw LC, Barnes MP, Rodgers H. Response to Letter by Munin et al Regarding Article, "Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain". Stroke 2011, 42(7), E413.
• Shaw L, Rodgers H. Botulinum toxin to treat spasticity after stroke. Stroke Matters 2010, (6), 12-13.
• Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS Investigators. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technology Assessment 2010, 14(26), 1-+.
• Shaw L, Rodgers H. Botulinum toxin type A for upper limb spasticity after stroke. Expert Review of Neurotherapeutics 2009, 9(12), 1713-1725.
• Rodgers H, Shaw L, Price C, Wijck Fvan, Barnes M, Graham L, Ford GA, Shackley P, Steen N. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Trials 2008, 9(1), 59.